These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3718726)

  • 1. Experimental procedure for estimating the dissociation constant of noncompetitive interactants. Part I.
    Orsetti M
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):51-7. PubMed ID: 3718726
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental procedure for estimating the dissociation constant of noncompetitive interactants. Part II.
    Orsetti M
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):59-65. PubMed ID: 3718727
    [No Abstract]   [Full Text] [Related]  

  • 3. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of competitive ligand binding results in QSAR studies.
    Gómez-Jeria JS
    Farmaco Sci; 1985 May; 40(5):299-302. PubMed ID: 4007152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Receptors; from idea to reality].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1983 Jul; 127(28):1235-8. PubMed ID: 6310420
    [No Abstract]   [Full Text] [Related]  

  • 6. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    MacKay D
    J Pharm Pharmacol; 1978 May; 30(5):312-3. PubMed ID: 26747
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantification of receptor interactions using binding methods.
    Lazareno S
    J Recept Signal Transduct Res; 2001; 21(2-3):139-65. PubMed ID: 11757681
    [No Abstract]   [Full Text] [Related]  

  • 8. The classification of drugs and drug receptors in isolated tissues.
    Kenakin TP
    Pharmacol Rev; 1984 Sep; 36(3):165-222. PubMed ID: 6093156
    [No Abstract]   [Full Text] [Related]  

  • 9. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

  • 10. [A microcomputer program for the analysis of the drug-receptor bond using radioligands].
    García AJ; Ríus F; López DR; Martos F; de la Cruz JP; Gómez JA; Sánchez de la Cuesta F
    Arch Farmacol Toxicol; 1986 Apr; 12(1):71-82. PubMed ID: 3755582
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental allergy as a model of pharmacological activity].
    Alonso de Florida F
    Bol Estud Med Biol; 1983; 32(7-8 Suppl 1):53-65. PubMed ID: 6100436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drugs: molecular pharmacology, sites of action and drug receptors].
    Astier A
    Soins; 1984 Oct; (439):13-25. PubMed ID: 6569695
    [No Abstract]   [Full Text] [Related]  

  • 13. Computerized graphic methods for determining dissociation constants of agonists, partial agonists, and competitive antagonists in isolated smooth muscle preparations.
    Zaborowsky BR; McMahan WC; Griffin WA; Norris FH; Ruffolo RR
    J Pharmacol Methods; 1980 Sep; 4(2):165-78. PubMed ID: 7453193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical treatment of events between the drug-receptor association and the effect.
    Gero A
    J Theor Biol; 1983 Sep; 104(2):249-59. PubMed ID: 6645557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pA2 and receptor differentiation: a statistical analysis of competitive antagonism.
    Tallarida RJ; Cowan A; Adler MW
    Life Sci; 1979 Aug; 25(8):637-54. PubMed ID: 388133
    [No Abstract]   [Full Text] [Related]  

  • 16. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology.
    Jenkinson DH; Barnard EA; Hoyer D; Humphrey PP; Leff P; Shankley NP
    Pharmacol Rev; 1995 Jun; 47(2):255-66. PubMed ID: 7568328
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of the relation between pharmacokinetic processes and pharmacological effects in humans].
    Dorokhov VV; Kholodov LE
    Farmakol Toksikol; 1985; 48(5):119-25. PubMed ID: 3908140
    [No Abstract]   [Full Text] [Related]  

  • 18. Acinar factors in drug processing: protein binding, futile cycling, and cosubstrate.
    Pang KS
    Drug Metab Rev; 1995; 27(1-2):325-68. PubMed ID: 7641582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetic polymorphism of drug metabolism: therapeutic implications].
    Eichelbaum M
    Bull Soc Sci Med Grand Duche Luxemb; 1985; 122(1):9-10. PubMed ID: 4042270
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical chronopharmacology].
    Markiewicz A
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1611-4. PubMed ID: 6687238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.